-
Radius Health’s Tymlos earns FDA approval
WASHINGTON — The Food and Drug Administration on Friday approved Tymlos (abaloparatide) injection for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy, manufacturer Radius Health said in a statement. In postmenopausal women with osteoporosis, Tymlos is intended to reduce the risk of vertebral and nonvertebral fractures.
-
ShopRite joins Aetna’s national network of preferred pharmacies
KEASBEY, N.J. — ShopRite has joined Aetna’s national network of preferred pharmacies. Effective immediately, Aetna Medicare members with drug coverage can fill their prescriptions at preferred copay levels at any ShopRite pharmacy.
According to ShopRite, this means Aetna Medicare customers can get their prescriptions at low, preferred cost shares while they shop at ShopRite pharmacies.
